Results 91 to 100 of about 3,749 (163)

17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study. [PDF]

Am J Obstet Gynecol, 2017
Nelson DB, McIntire DD, McDonald J, Gard J, Turrichi P, Leveno KJ.   +5 more
europepmc   +1 more source

Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. [PDF]

Am J Obstet Gynecol, 2016
Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR).   +13 more
europepmc   +1 more source

Characteristics of glucose transport across the microvillous membranes of human term placenta Características del transporte de glucosa a través de las membranas con microvellosidades de la placenta humana a término

Nutrición Hospitalaria, 2006
Transport characteristics of D-glucose were studied in the microvillous vesicles isolated from the human term placenta. Transport occurred by selective and rapid facilitated diffusion system which was inhibitable by phloretin and HgCl2. The transport was
Ravinderjit Kaur Anand, Usha Kanwar, Sankar Nath Sanyal   +2 more
doaj  

Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort. [PDF]

Am J Obstet Gynecol, 2016
Turitz AL, Bastek JA, Purisch SE, Elovitz MA, Levine LD.   +4 more
europepmc   +1 more source

What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth. [PDF]

Semin Perinatol, 2016
Caritis SN, Feghali MN, Grobman WA, Rouse DJ, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network.   +4 more
europepmc   +1 more source

Vaginal administration of 17-alpha hydroxyprogesterone caproate appears to be safe in non-pregnant female rats and rabbits. [PDF]

Xenobiotica
Shaik IH, Chaphekar N, Vasudevan V, Alshabi A, AlOwaifeer A, Zhao W, Caritis S, Venkataramanan R.   +7 more
europepmc   +1 more source

The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth. [PDF]

Am J Obstet Gynecol
Nelson DB, Herrera CL, McIntire DD, Cunningham FG.   +3 more
europepmc   +1 more source

Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth. [PDF]

Adv Biomed Res, 2015
Rouholamin S, Zarean E, Sadeghi L.
europepmc   +1 more source

852: Effect of 17-alpha hydroxyprogesterone caproate on labor at term [PDF]

American Journal of Obstetrics and Gynecology, 2016
Amy E. Judy, Yasser Y. El-Sayed, Yair J. Blumenfeld   +2 more
openaire   +1 more source